The study focused on cancers of the digestive system, a group that includes tumors of the esophagus, stomach, colon, rectum, pancreas, liver, and biliary tract. These cancers are among the most common and most lethal malignancies worldwide, and their outcomes depend heavily on how early they are detected. When a cancer is caught through organized screening, opportunistic testing, or a prompt diagnostic workup of symptoms, patients are far more likely to receive curative treatment. When it is diagnosed in an emergency department, the disease is typically advanced, the patient is often acutely unwell, and survival prospects deteriorate sharply.

Between 2018 and 2021, the researchers identified all individuals diagnosed with digestive system cancers in their Northern Italian study population and classified them according to whether they had pre-existing impairments. Drawing on administrative healthcare records, the team was able to characterize impairments across heterogeneous categories, including mental function impairments and neuromusculoskeletal impairments, and to trace how each person’s cancer came to medical attention. The diagnostic route was categorized as either emergency presentation or a non-emergency pathway, and the researchers followed all patients for at least one year to assess survival.

The headline finding is difficult to ignore. Among people with impairments, 51.8 percent of digestive system cancers were diagnosed following emergency presentation, compared with 37.9 percent among people without impairments. After adjusting for socio-demographic and clinical factors, this translated into a 41 percent higher odds of emergency diagnosis for people with impairments, with an adjusted odds ratio of 1.41 and a 95 percent confidence interval of 1.23 to 1.61. The association was particularly pronounced for individuals with impairments of mental and neuromusculoskeletal functions, suggesting that the mechanisms driving delayed detection may differ across disability groups but converge on the same adverse outcome.

Survival data reinforced the scale of the problem. Individuals with pre-existing impairments had significantly higher mortality within one year of diagnosis, with a hazard ratio of 1.36 and a 95 percent confidence interval of 1.26 to 1.46. Critically, this excess risk persisted after the researchers accounted for a broad range of socio-demographic and clinical characteristics, indicating that the survival gap cannot be explained away by age, sex, socioeconomic position, tumor type, or comorbidities alone. The finding points instead to systemic differences in how, and how quickly, people with disabilities access and move through cancer diagnostic and treatment services.

Why might disability so strongly shape the route to diagnosis? The study itself does not establish mechanisms, but the epidemiological pattern is consistent with several plausible pathways that clinicians and health services researchers have long hypothesized. Communication barriers are a leading candidate: patients with mental function impairments may struggle to describe symptoms, and clinicians may find it harder to elicit a reliable history, so that early warning signs of gastrointestinal cancer are missed or misattributed. Neuromusculoskeletal impairments can complicate physical examinations, imaging, and procedures such as endoscopy, potentially making both patients and providers more hesitant to pursue timely investigation.

Access barriers compound these clinical challenges. People with disabilities may face practical obstacles in attending outpatient appointments, arranging transport, or navigating hospital environments that are not physically adapted to their needs. Caregiver availability, health literacy, and the tendency of both patients and physicians to prioritize disability-related conditions over new symptoms can all contribute to what researchers call diagnostic overshadowing, in which a new and serious illness is overlooked because attention is focused on a pre-existing condition. When symptoms finally become unbearable, the result is often an emergency department visit, which is precisely the pattern the data reveal.

The consequences of emergency presentation are well documented in oncology. Emergency-diagnosed cancers are typically diagnosed at later stages, and patients are frequently too unstable for immediate optimal treatment. Emergency pathways also fragment care: rather than a planned diagnostic sequence leading to a multidisciplinary treatment decision, patients arrive acutely ill and are managed reactively. For digestive system cancers in particular, where surgical resection offers the best chance of cure for many tumor types, delays that allow disease progression can be decisive. The one-year mortality excess observed in this study is therefore plausibly linked, at least in part, to the elevated rate of emergency diagnosis, although the adjusted survival analysis suggests that disability-related disadvantage may extend beyond diagnostic route alone.

The study’s methodology deserves attention because it strengthens the credibility of its conclusions. By linking cancer registry data, which capture standardized clinical information on every diagnosed malignancy, with administrative healthcare databases, which record healthcare contacts and diagnoses over time, the researchers could identify pre-existing impairments across the whole population rather than relying on self-report or small clinical samples. This population-based cohort design minimizes selection bias and allows findings to be generalized to the broader community, something that hospital-based studies of disability and cancer have struggled to achieve. The analysis of multiple impairment categories is also a methodological advance, since disability is heterogeneous and treating it as a single binary variable can obscure important differences between, for example, cognitive, sensory, and mobility-related impairments.

The implications for health policy and clinical practice are significant. Northern Italy is served by a universal healthcare system with organized cancer screening programs, which makes the persistence of such disparities particularly striking. If these gaps exist in a high-income European setting with comprehensive coverage, they are likely to be at least as severe in health systems with fewer resources or less equitable access. The authors note that population-based evidence on cancer diagnosis and survival among people with disabilities has remained limited, and this study helps fill that gap with concrete, quantified estimates that can inform intervention design.

Potential responses include adapting screening and diagnostic services to be more accessible, training primary care clinicians to recognize cancer symptoms in patients with communication or cognitive impairments, involving caregivers more systematically in symptom monitoring, and building flagging systems that alert clinicians when patients with disabilities present with symptoms that warrant urgent investigation. Reducing emergency presentations is a well-recognized target in cancer control more broadly, and this study makes clear that disability-focused strategies must be part of that effort. As the population ages and the number of people living with disabilities grows, ensuring equitable cancer outcomes for this group will become an increasingly central test of whether modern health systems can deliver on the promise of care that leaves no one behind.

Subject of Research: Disability-related disparities in the diagnosis and survival of digestive system cancers

Article Title: Disability related disparities in diagnosis and survival of digestive system cancers in Northern Italy

Article References: Pennisi, F., Buzzoni, C., Gervasi, F., Greco, M. T., Signorelli, C., Russo, A. G., & Renzi, C. (2026). Disability related disparities in diagnosis and survival of digestive system cancers in Northern Italy. Nature Communications. https://doi.org/10.1038/s41467-026-78262-w

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78262-w

Keywords: cancer epidemiology, disability, health disparities, emergency presentation, digestive system cancers, cancer survival, diagnostic delay, Northern Italy, cancer registry, health equity, one-year mortality, population-based cohort

The research team, led by Atinuke G. Oyinbo and Saif Al Amin of the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, defined emergency presentation as a cancer diagnosis preceded by a recent emergency department visit. They then split this group into two clinically distinct categories: emergency presentation inpatients, who were admitted to the hospital after their emergency visit, and emergency presentation outpatients, who were discharged with instructions for follow-up care. The numbers were stark. Overall, 37 percent of patients were diagnosed through involvement with the emergency department, with 30 percent falling into the inpatient category and 7 percent into the outpatient group. That means nearly one in three older adults with multiple myeloma was already sick enough to require hospitalization by the time the cancer was identified.

What makes this figure especially concerning is what emergency presentation typically signals for cancer outcomes. Previous research, including a large international study published in Lancet Oncology and a companion analysis of more than 929,000 Medicare beneficiaries with common cancers, has linked diagnosis through emergency admission to substantially higher short-term mortality. For a disease like multiple myeloma, which is often preceded by a detectable precursor state and can be identified with relatively simple blood tests, the high rate of emergency diagnosis suggests a systemic failure to catch the cancer earlier, when treatment is generally more effective and less punishing.

The study’s technical strength lies in its use of iteratively adjusted statistical models, which allowed the researchers to estimate the independent association of each patient-level factor with emergency diagnosis while accounting for the influence of all others. Through this approach, a consistent constellation of risk factors emerged. The oldest patients, women, and people from several racial and ethnic minority groups, including non-Hispanic Black, Hispanic, Asian American, and Native Hawaiian or Other Pacific Islander patients, were all more likely to be diagnosed through the emergency department. So were those who were unmarried, dually eligible for both Medicaid and Medicare, living in counties with the lowest socioeconomic status, residing in rural areas, or classified as frail using a claims-based frailty index. Higher healthcare utilization in the year before diagnosis also predicted emergency presentation, a finding that initially seems paradoxical but becomes clearer when the timeline is examined closely.

That timeline is where the study delivers its most provocative insight. The researchers compared symptom-related healthcare utilization between patients diagnosed through emergency presentation and those diagnosed through other routes in the year preceding diagnosis. Remarkably, the two groups were broadly comparable in how often they sought care for symptoms that could plausibly relate to myeloma during most of that year. But in the final month before diagnosis, utilization in the emergency presentation group spiked dramatically. This pattern suggests that many patients who ended up in emergency rooms were not avoiding the healthcare system altogether. They were seeing doctors, reporting symptoms, and undergoing evaluations, yet the underlying cancer was not recognized until they became acutely ill.

The biological explanation for this diagnostic blind spot lies in the nature of the disease itself. Multiple myeloma arises from plasma cells in the bone marrow and produces its damage through a constellation of nonspecific mechanisms: anemia causing fatigue, bone destruction causing pain, kidney impairment, elevated calcium, and increased susceptibility to infections. Each of these features can be attributed to far more common conditions in an aging population. A 76-year-old with back pain and tiredness is far more likely to be evaluated for degenerative joint disease or depression than for a plasma cell disorder. The median age of patients in this study was 76, an age at which multiple competing health problems routinely coexist, further muddying the diagnostic picture. Prior systematic reviews have quantified substantial delays between first symptoms and diagnosis in myeloma, and UK data from the Haematological Malignancy Research Network have documented similar patterns of unplanned diagnostic routes in this cancer.

The disparities identified in the study add a layer of health equity concern that extends beyond clinical medicine. Dual eligibility for Medicaid and Medicare serves as a proxy for low income, and its association with emergency diagnosis suggests that financial barriers to proactive care may push patients toward emergency departments as their default entry point. Rurality and low county socioeconomic status point to structural issues of access, including fewer primary care providers, longer travel distances, and limited availability of specialist referrals. The finding that non-Hispanic Black patients face elevated odds of emergency diagnosis is particularly significant given that Black Americans carry roughly twice the incidence of multiple myeloma compared with white Americans, a disparity rooted in both biology and healthcare access. Prior work has documented that Black patients with myeloma experience delays and disparities at multiple points along the diagnostic pathway, and this study confirms that the emergency department remains a disproportionate site of first diagnosis for this population.

Frailty emerged as another powerful predictor, and its role deserves careful interpretation. The claims-based frailty index used in the study captures accumulated deficits in health status, and frailer patients are both more likely to experience acute decompensation that lands them in the emergency room and more likely to have their myeloma symptoms attributed to general decline. There is also a practical dimension: frail older adults often depend on care partners to navigate appointments, communicate symptoms, and follow through on referrals, and research on the role of companions in oncology consultations suggests that the presence or absence of such support can meaningfully shape whether concerning findings get escalated. Unmarried status, which was independently associated with emergency diagnosis, may reflect the absence of that advocacy layer.

The study’s implications for policy and practice are concrete. Because the researchers found that symptom-related healthcare utilization was similar between emergency and non-emergency groups in the months before diagnosis, the problem appears to be not a lack of contact with the system but a failure to connect symptoms to the right diagnostic workup. This points toward interventions at the primary care level, including better use of blood tests such as serum protein electrophoresis when older patients present with unexplained anemia, bone pain, or kidney dysfunction. It also supports the development of rapid diagnostic clinics for suspected cancer, models that have been piloted at several US cancer centers and that aim to compress the time from suspicious findings to definitive workup. The precursor state of myeloma, monoclonal gammopathy of undetermined significance, is detectable in a meaningful fraction of the older population, and large screening efforts such as the iStopMM study in Iceland have demonstrated that population-level identification of this precursor is feasible, though the question of whether such screening should be broadly implemented remains open.

What the SEER-Medicare data ultimately reveal is a diagnosis arriving too late for a preventable share of patients, and a healthcare system that touches these patients repeatedly before the moment of recognition. The 37 percent emergency presentation rate for multiple myeloma stands as a benchmark against which future interventions can be measured. Reducing it will require clinicians to lower their threshold for ordering the simple tests that unmask this cancer, health systems to build pathways that route suspicious findings quickly out of the emergency department and into definitive care, and policymakers to address the socioeconomic and geographic barriers that make the emergency room the only door some patients feel they can walk through. Until then, the great imitator will continue to announce itself in the least forgiving setting imaginable.

Subject of Research: Emergency department involvement in the diagnosis of multiple myeloma among older US adults

Article Title: Emergency diagnosis of multiple myeloma: a SEER-Medicare study

Article References: Oyinbo, A. G., Al Amin, S., LeBlanc, M. R., Keene, S. A., Hinton, S. P., Kurian, A. W., Pruitt, S. L., Pettit, N., Mullins, M. A., Lyratzopoulos, G., & Thompson, C. A. (2026). Emergency diagnosis of multiple myeloma: a SEER-Medicare study. Cancer Causes & Control, 37(10), Article 175. https://doi.org/10.1007/s10552-026-02263-9

Image Credits: AI Generated

DOI: 10.1007/s10552-026-02263-9

Keywords: multiple myeloma, emergency presentation, SEER-Medicare, cancer diagnosis, health disparities, older adults, emergency department, diagnostic delay, healthcare utilization, frailty, plasma cell disorder, cancer epidemiology